Gyre Therapeutics, Inc. (GYRE) stock
GYRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/3020% below fair value
$4.21−0.31 (-6.86%)
Close on Nov 20, 2026Market cap $469.46MP/E –Yield –
Gyre Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Gyre Therapeutics's market cap was $451.70M on Nov 11, 2026, against $704.40M a year earlier. Over the last 5 years it ranged from $124.60M to $1.39B, with a median of $666.29M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $451.70M | -29.6% |
| 2025 | Dec 31, 2025 | $641.69M | -38.2% |
| 2024 | Dec 31, 2024 | $1.04B | +6.4% |
| 2023 | Dec 29, 2023 | $975.66M | +289.7% |
| 2022 | Dec 30, 2022 | $250.35M | -17.0% |
| 2021 | Dec 31, 2021 | $301.64M | -85.6% |
| 2020 | Dec 31, 2020 | $2.09B | +70.1% |
| 2019 | Dec 31, 2019 | $1.23B | -13.1% |
| 2018 | Dec 31, 2018 | $1.41B | +60.3% |
| 2017 | Dec 29, 2017 | $881.90M | +657.8% |
| 2016 | Dec 30, 2016 | $116.38M | -78.3% |
| 2015 | Dec 31, 2015 | $535.78M | +428.2% |
| 2014 | Dec 31, 2014 | $101.44M | -36.4% |
| 2013 | Dec 31, 2013 | $159.42M | -5.1% |
| 2012 | Dec 31, 2012 | $167.99M | -20.8% |
| 2011 | Dec 30, 2011 | $212.19M | -72.6% |
| 2010 | Dec 31, 2010 | $775.36M | – |
See a number that looks wrong?